NCT04051320View on ClinicalTrials.gov

Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 2, 2020

Primary Completion Date

July 15, 2022

Study Completion Date

July 19, 2022

Conditions
Perinatal DepressionPost Partum DepressionDepression, PostpartumDepression
Interventions
DRUG

Leuprolide Acetate 3.75 MG/ML

3.75 mg/month leuprolide acetate intramuscular injection

DRUG

Estradiol 2 Mg tablet

2 mg estradiol tablet

DRUG

Micronized progesterone

200 mg micronized progesterone tablets

Trial Locations (1)

27514

University of North Carolina at Chapel Hill School of Medicine, Chapel Hill

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT04051320 - Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model | Biotech Hunter | Biotech Hunter